Dr. Mohammad Alhomoud

Dr. Mohammad Alhomoud, MBBS, is a medical oncologist and hematologist specializing in blood and bone marrow transplantation, including stem cell transplants, at Memorial Sloan Kettering Cancer Center. He sees patients at Memorial Hospital and at the David H. Koch Center for Cancer Care, providing expert treatment for a range of blood cancers including acute leukemia, lymphoma, and multiple myeloma. Central to his clinical philosophy is a commitment to patient education and shared decision-making, recognizing that a blood cancer diagnosis can be overwhelming and that informed patients are better equipped to navigate complex treatment pathways.

His research is focused on improving outcomes of bone marrow transplantation and cellular therapy while reducing their adverse effects. In one key study, he and his colleagues demonstrated in animal models that low-dose radiation therapy enhances the efficacy of CAR T cell therapy without increasing toxicity, laying the groundwork for future clinical trials exploring this approach. In a separate line of investigation, he contributed to the development of a novel diagnostic tool for detecting thrombotic microangiopathy, a serious and relatively common complication of bone marrow transplantation caused by a rare immune disturbance that activates platelets and promotes harmful blood clot formation. These findings reflect his dedication to translating laboratory insights into meaningful clinical advances for patients with blood cancers.

Outside of medicine, Dr. Alhomoud is an avid table tennis player and enjoys hiking in the fall and biking in Central Park, bringing the same discipline and enthusiasm to his personal pursuits as he does to his medical practice.